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CASE REPORT
Acute HIV infection may present as a mononu-
cleosis type of syndrome with a constellation of 
nonspecific symptoms, detectable in only 50-
70% of infected patients (Schacker et al., 1996). 
A limited number of cases may present neu-
rological features, such as aseptic meningitis, 
encephalitis, meningoencephalitis, often asso-
ciated with a more rapid progression to AIDS 
(Castellanos et al., 1994; Hassin-Baer et al., 
1998; Boissé et al., 2008; McArthur et al., 2005; 
Andrade et al., 2014).
We describe a case of HIV-correlated meningo-
encephalitis in a young woman, who has spon-
taneously controlled her HIV infection from se-
roconversion to date, in the absence of antiret-
roviral therapy. 
A 19-year-old woman was admitted to the In-
fectious Diseases Operative Unit in July 2008. 
The patient showed fever (39°C), severe leth-
argy, neck stiffness and pyramidal signs. Elec-
troencephalogram analysis recorded a strong 
depression of cerebral electric activity and 
nuclear magnetic resonance indicated inflam-
mation in the supratentorial and subtentorial 
leptomeninges. The metabolic panel showed 
normal values. The percentage of lymphocytes 
and monocytes was significantly increased as 
was C-reactive protein. 
Cerebrospinal fluid (CSF) analysis disclosed 
pleocytosis with an increased white blood cell 
count (35 cells/mmc) and modified protein lev-
els (2.78 g/L). Direct microscopic examination 
and further cultures ruled out bacteria and fun-
gi. Cryptococcus antigen was also negative as 
was the detection of antibodies (IgM and IgG) 
to Borrelia burgdorferi and West Nile Virus. In 
addition, PCR analysis excluded CMV, EBV, 
HSV-1/2, VZV, Enterovirus, Adenovirus and 
JCV. All blood cultures showed negative results.
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We describe the case of a young woman with an acute HIV infection characterized at onset by neurological fea-
tures. The patient spontaneously controlled her HIV infection and recovered in a short period of time.
The patient’s clinical and virological history showed a peculiar evolution of HIV infection, with an MDR HIV-1 in 
CSF and a wild HIV strain in PBMCs. The patient’s PBMC showed a rapid shift from a wild type to an MDR strain 
in few days.
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Due to a strong suspicion of acute meningoen-
cephalitis of unknown origin, the patient was 
empirically treated with ceftriaxone, ampi-
cillin, acyclovir and dexamethasone. The day 
after hospitalization, her plasma sample was 
also analyzed for HIV infection. A diagnosis of 
acute HIV infection was established by a pos-
itive fourth generation test, a serum reactivi-
ty to only HIV p24 and p55 and a low level of 
avidity index (0.3 OD) (Re et al., 2012). T lym-
phocytes [T CD4+ 740/mmc (25%), CD8+ 1540/
mmc (52%)] showed an inversion of the CD4/
CD8 ratio and viral load and HIV RNA load was 
assessed at 3.6x103 copies/ml (Figure 1).
Further history-taking identified the patient’s 
partner, a 20 year-old male, vertically infected 
at birth and already followed by the Infectious 
Disease Unit, suggesting a sexual transmission, 
even though the two patients referred constant-
ly protected sexual intercourse. The case pa-
tient’s partner had a complex clinical history, 
with several therapeutic approaches for accu-
mulating resistance-correlated mutations and, 
at the time of this finding, he presented an ele-
vated blood viral load (1x104 HIV-RNA copies/
ml).
Since HIV-1 RNA from our patient’s plasma 
was not amplified, probably due to suboptimal 
sample storage, proviral DNA, successfully ob-
tained from blood PBMCs, revealed wild type 
HIV-1 B subtype (R5 tropic virus) without any 
drug resistance mutations. Meanwhile, a mul-
tidrug-resistant R5 HIV with several mutations 
inducing resistance to all NRTIs, NNRTIs and 
PIs was detected in the CSF.
To support the clinical investigation, we recon-
structed the transmission events by a specific 
dataset, including 7 HIV-1 pol gene isolates (3 
from female and 4 from male sequences at dif-
ferent time points) previously classified as B 
subtype, 37 HIV-1 B subtype “local controls” 
and 57 subtype B reference sequences (Bon et 
al., 2010; Falasca et al., 2014). The dataset se-
quences were aligned and the best fitting nucle-
otide substitution model selected (Lo Presti et 
al., 2012; Ciccozzi et al., 2012). 
Time-measured phylogeny and evolutionary 
rates were inferred using a Bayesian Markov 
Chain Monte Carlo (MCMC) approach (Beast 
version 1.8.0 http://beast.bio.ed.ac.uk) (Drum-
mond et al., 2005) implementing a GTR + I + G 
model. The MCMC was run until convergence 
was achieved on the basis of the effective sam-
pling site (ESS). Only ESS values >250 were 
accepted. 
The Bayesian Skyline Plot (BSP) demographic 
model under a relaxed (uncorrelated log nor-
mal) clock was selected on the basis of Bayes’ 
FIGURE 1 - Time schedule of virological parameters in our patient from admission to date.
MDR strain
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Factors (2 ln BF >55). Using both “reference 
sequences” and “local controls”, the Bayesian 
phylogenetic tree showed that the patient’s iso-
lates formed a significant monophyletic cluster 
(posterior probability =1) (Figure 2). The male 
sequence labelled as 48@08 was at the root 
of the female’s sequences. The node connect-
ing the female sequences (labelled as 49@08, 
45@08, 44@08) showed a 95% HPD tMRCA 
estimate of 2004-2008.8. Besides confirming 
the transmission event and the direction of the 
transmission, our results estimated the date of 
the transmission event with good approxima-
tion between June and August 2008.
Eleven days post-admission, our patient’s blood 
and CSF samples showed 1700 and 57 HIV cop-
ies/ml respectively (Figure 1). In addition, viral 
characterization performed PBMCs showed 
a shift from a wild HIV to MDR HIV-1 strain, 
with the same aminoacid changes present in 
the CSF sample. Since the patient showed a 
good state of health and favourable laboratory 
parameters (HIV RNA constantly undetecta-
ble and lymphocyte T CD4+ cell count at 1722/
mmc), the medical staff decided not to initiate 
antiretroviral therapy and to check the patient 
at short intervals of time.
Further controls (at time 60 and afterwards) 
confirmed a lack of viral replication and opti-
mal values of lymphocyte T CD4+ cell count. 
Both these parameters, in addition to a good 
overall health condition, confirmed the deci-
sion not to start antiretroviral therapy.
DISCUSSION
We reported the case of a young female patient 
with an acute infection characterized by an HIV 
wild type in PBMCs and an MDR HIV in cere-
brospinal liquid. Despite the presence of neuro-
logical symptoms at onset, often classified as a 
FIGURE 2 - Bayesian phylogenetic tree of 101 HIV-1 subtype B Pol sequences implementing a relaxed molecular 
clock. The transmission event is evident in bold. The asterisks (*) along a branch represent significant statistical 
support for the cluster subtending the branch (posterior probability >98%). The time of the most recent common 
ancestor (tMCRA), and the credibility interval based on 95% highest posterior density interval (95% HPD) are 
also reported.
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negative marker, the patient rapidly recovered 
and showed a complete remission of the neu-
rological picture. Moreover, the clearance of 
viral load and the assessment of optimal CD4 
cell levels were achieved without antiretroviral 
therapy. Interestingly the HIV-1 strain isolated 
from CSF was an MDR strain with a large set 
of mutations able to escape most antiretrovi-
ral compounds and the HIV isolated in PBMCs 
showed a shift from a wild HIV to HIV-1 MDR 
tropic strain in few days.
Despite the absence of specific antiviral thera-
py, HIV disease progression was not accelerated 
and plasma viral load clearance was achieved 
and has been maintained, at least to date (six 
years later from onset), suggesting that our pa-
tient might be considered an elite non progres-
sor.
Even if we are aware that host factors and low 
fitness of the MDR variant might play a crucial 
role in determining a non progressive evolu-
tion of the disease, the great benefits of early 
antiretroviral therapy, also assessed by recent 
guidelines (Antinori et al., 2011), must not be 
underestimated.
The work was performed at the Microbiology 
Section of the Department of Experimental, Di-
agnostic and Specialty Medicine, School of Med-
icine, University of Bologna, Italy
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